歌礼制药-B(01672)发布公告，该公司于2025年12月17日斥资260.12万港元回购20万股股份，每股回购价 格为12.55-13.17港元。 ...

智通财经APP讯，歌礼制药-B(01672)发布公告，该公司于2025年12月17日斥资260.12万港元回购20万股 股份，每股回购价格为12.55-13.17港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 歌禮製藥有限公司 呈交日期： 2025年12月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01672 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事 ...

Market Performance - The Hong Kong stock market experienced a narrow fluctuation in the morning and a strong rally in the afternoon, with the Hang Seng Index rising by 0.92% to 25,468.78 points, the Hang Seng Tech Index increasing by 1.03% to 5,457.95 points, and the National Enterprises Index up by 0.98% to 8,843.57 points [1] - Major technology stocks mostly rose, with Alibaba up 1.25%, Tencent Holdings up 1.42%, JD Group up 1.26%, and Meituan up 1.81% [1] - The aviation sector showed strong performance, with China Southern Airlines rising over 5%, while financial stocks also saw gains, with China Life Insurance increasing over 4% [1] - The metals sector led the gains, with Tianqi Lithium up nearly 6%, Ganfeng Lithium up over 5%, and Luoyang Molybdenum up over 2% [1] - Semiconductor stocks also rose, with Shanghai Fudan up 4%, Huahong Semiconductor up nearly 3%, and SMIC up over 2% [1] Corporate News - China Energy Construction (03996.HK) announced the official operation of the first phase of the Zhongnengjian Songyuan Hydrogen Energy Industrial Park project [2] - China Pacific Insurance (02601.HK) reported that its cumulative original insurance premium income for the first 11 months reached RMB 250.32 billion, a year-on-year increase of 9.4%, while its property insurance premium income was RMB 187.68 billion, up 0.3% [2] - Hansoh Pharmaceutical (03692.HK) entered into a licensing agreement with Glenmark for Amivantamab, which includes an upfront payment and potential milestone payments exceeding USD 1 billion [2] Financing Activities - Yuexiu Property (00123.HK) secured a term loan financing of HKD 500 million [3] - China Railway Construction (01186.HK) plans to issue company bonds with a total amount not exceeding RMB 4 billion [4] - Genscript Biotech (01672.HK) increased its share buyback fund from a maximum of HKD 300 million to HKD 500 million [5] - Tencent Holdings (00700.HK) repurchased 1.067 million shares for approximately HKD 636 million at prices ranging from HKD 592.5 to HKD 602.5 [6] - Xiaomi Group (01810.HK) repurchased 7.2 million shares for HKD 294 million at prices between HKD 40.36 and HKD 41.00 [7] - Kuaishou Technology (01024.HK) repurchased 1.8231 million shares for HKD 116 million at prices from HKD 63.05 to HKD 64.4 [8] - Geely Automobile (00175.HK) repurchased 299,900 shares for approximately HKD 50.54 million at prices between HKD 16.72 and HKD 17.2 [9] Institutional Insights - According to China Merchants Securities, the recent weakness in the Hong Kong stock market is attributed to southbound capital returning to A-shares due to new public fund benchmark regulations, concerns over IPO financing, and the upcoming peak of stock unlocks [10] - Huatai Securities noted that while the market's downside is manageable, the upside potential has not yet opened up, with market sentiment indicators remaining in a pessimistic range [10] - China Merchants Securities also highlighted that the Hong Kong market has not stabilized after overseas interest rate cuts, primarily due to internal liquidity issues [10]

Market Overview - The Hong Kong stock market experienced a rebound on December 17, with the Hang Seng Index rising by 0.22% to 25,291.4 points, the Hang Seng Tech Index increasing by 0.02% to 5,403.74 points, and the National Enterprises Index up by 0.27% to 8,781.76 points, while the Red Chip Index fell by 0.11% to 4,055.42 points [1] Company News - China Energy Construction (03996.HK) announced the official production commencement of the first phase of the Zhongnengjian Songyuan Hydrogen Energy Industrial Park project [2] - China Coal Energy (01898.HK) reported a total coal sales volume of approximately 234 million tons for the first 11 months, a year-on-year decrease of 8.7%, with November sales at 21.74 million tons, down 15.7% year-on-year [2] - China Pacific Insurance (02601.HK) disclosed that its cumulative original insurance premium income for Pacific Life reached RMB 250.32 billion, a year-on-year increase of 9.4%, while Pacific Property's premium income was RMB 187.68 billion, up 0.3% year-on-year [2] - Hansoh Pharmaceutical (03692.HK) entered into a licensing agreement with Glenmark for Amivantamab, which includes an upfront payment and potential milestone payments exceeding USD 1 billion, along with tiered royalties on net sales in the licensed territory [2] Financing Activities - Yuexiu Property (00123.HK) secured a term loan financing of HKD 500 million [3] - China Railway Construction (01186.HK) plans to issue up to HKD 4 billion of perpetual corporate bonds [4] - Genscript Biotech (01672.HK) increased its share buyback fund from a maximum of HKD 300 million to HKD 500 million [5] - Tencent Holdings (00700.HK) repurchased 1.067 million shares for approximately HKD 636 million at prices ranging from HKD 592.5 to HKD 602.5 [6] - Xiaomi Group (01810.HK) repurchased 7.2 million shares for approximately HKD 294 million at prices between HKD 40.36 and HKD 41.00 [7] - Kuaishou Technology (01024.HK) repurchased 1.8231 million shares for approximately HKD 116 million at prices from HKD 63.05 to HKD 64.4 [8] - Geely Automobile (00175.HK) repurchased 299,900 shares for approximately HKD 50.54 million at prices between HKD 16.72 and HKD 17.2 [9] Institutional Insights - CMB International noted that the recent weakness in the Hong Kong stock market is attributed to southbound capital returning to A-shares due to new public fund benchmark regulations, concerns over IPO financing, and a peak in lock-up expirations, while the market has potential for a year-end recovery [10] - Ping An International observed that the market sentiment index for Hong Kong stocks has been volatile since November, influenced by fluctuating expectations of U.S. interest rate cuts and corrections in the U.S. AI sector, with the forward P/E ratio of the Hang Seng Index at 12.7 times, down 5% from its yearly peak [10] - CMB Securities indicated that the Hong Kong market has not stabilized post U.S. rate cuts, primarily due to internal liquidity issues, including the implementation of new public fund regulations and significant demand for capital [10]

Market Overview - The Hang Seng Index has short-term support at the 25,000 point level, with expectations of two interest rate cuts in 2026 following the Federal Reserve's recent 0.25% rate cut, which aligns with market predictions [2][4] - The Chinese economy is projected to grow around 5% this year, with a total economic volume expected to reach approximately 140 trillion yuan [9] - The Hong Kong stock market has seen significant gains this year, leading to profit-taking incentives as trading volume decreases [2][7] Company News - Alibaba (9988) launched the Wanxiang 2.6 series model, introducing the first role-playing feature in the domestic market [11] - Baidu (9888) reported that its no-code application platform, Miaoda, has generated over 500,000 business applications, creating value exceeding 5 billion yuan [11] - The Hong Kong Stock Exchange (0388) is currently processing over 300 listing applications, reflecting strong market interest [11] - Tencent's major shareholder, Prosus, is accelerating its share buyback program, utilizing funds from the sale of assets outside of Tencent [11] - AMD's CEO visited Lenovo Group to explore collaboration opportunities in advanced technologies [11] Sector Focus - The AI sector is gaining traction with the launch of AI glasses and smartphones, benefiting related industry stocks [8] - The biopharmaceutical sector is expected to thrive due to rising flu cases and favorable financing conditions following interest rate cuts [8] - The insurance sector in the Asia-Pacific region is projected to maintain a neutral outlook, supported by resilient performance and strong solvency [9]

12月17日，港股小幅高开，其中恒生指数涨0.03%报25243.59点，恒生科技指数涨0.09%报5407.36点， 国企指数涨0.12%报8768.33点，红筹指数涨0.08%报4063.38点。 越秀地产(00123.HK)：获授5亿港元的定期贷款融资。 中国铁建(01186.HK)：拟发行不超过40亿元可续期公司债券。 歌礼制药-B(01672.HK)：将股份购回资金由最多3亿港元增至最多5亿港元。 盘面上，大型科技股普遍高开飘红，腾讯控股涨0.08%，京东集团涨0.45%，小米集团涨0.93%，网易涨 0.66%，美团涨0.1%，快手涨0.47%，哔哩哔哩跌0.11%；黄金股高开，招金矿业涨超1%；中资券商股 活跃，弘业期货涨近1%；国际油价走低，石油股下跌；今日HASHKEY HLDGS上市，首日高开0.3%。 腾讯控股(00700.HK)：斥资约6.36亿港元回购106.7万股，回购价592.5-602.5港元。 企业新闻 小米集团-W(01810.HK)：斥资2.94亿港元回购720万股，回购价40.36-41.00港元。 中国能源建设(03996.HK)：投资建设的中能建松原氢能产业园(绿色 ...

【重大事项】 HASHKEY HLDGS(03887)香港公开发售获393.71倍认购 每股发售价6.68港元 【回购增减持】 腾讯控股(00700)12月16日耗资约6.36亿港元回购106.7万股 小米集团-W(01810)12月16日斥资2.94亿港元回购720万股 快手-W(01024)12月16日斥资1.16亿港元回购182.31万股 吉利汽车(00175)12月16日斥资5054.44万港元回购29.99万股 碧桂园服务(06098)12月16日耗资约3127.38万港元回购500万股 中远海控(01919)12月16日斥资4031.69万港元回购300万股 歌礼制药-B(01672)将股份购回资金由最多3亿港元增至最多5亿港元 红星美凯龙(01528)股东淘宝控股及新零售基金合计减持公司4164.66万股H股 金风科技(02208)股东和谐健康累计减持约3594.99万股股份 世纪联合控股(01959)控股权易主 获折让约66.78%提全购要约 12月17日复牌 【财报数据】 中国太保(02601)：太平洋人寿保险前11个月原保险保费收入为2503.22亿元 同比增长9.4% 中煤能源(0189 ...

中国能源建设(03996.HK)：投资建设的中能建松原氢能产业园(绿色氢氨醇一体化)项目一期工程正式投产运行。 中煤能源(01898.HK)：前11月商品煤销量为约2.34亿吨，同比减少8.7%。11月煤销量为2174万吨，同比减少15.7%。 中国太保(02601.HK)：前11月，太平洋人寿累计原保险保费收入为人民币2503.22亿元，同比增长9.4%，太平洋财险累计原保险保费收入为人民币1876.82亿 元，同比增长0.3%。 中国铁建(01186.HK)：拟发行不超过40亿元可续期公司债券。 智通财经12月16日讯（编辑 冯轶）智通财经为您带来今日港股重要公告 2）回购动态 1）公司要闻 翰森制药(03692.HK)：与GLENMARK就阿美替尼订立许可协议。 公告称，根据协议将获得首付款和后续可能累计超过十亿美元的监管和商业里程碑付款，以及授权区域内净销售额的分级特许权使用费。 越秀地产(00123.HK)：获授5亿港元的定期贷款融资。 腾讯控股(00700.HK)：斥资约6.36亿港元回购106.7万股，回购价592.5-602.5港元。 小米集团-W(01810.HK)：斥资2.94亿港元回购7 ...

歌礼制药-B(01672)发布公告，于2025年12月16日斥资260.99万港元回购20万股。 ...